Manager, QC Microbiology (Sterile Drug Manufacturing & Fill Finish) MannKind CorpManager, QC Microbiology (Sterile Drug Manufacturing & Fill Finish)Danbury, CTOur signature technologies - dry-powder formulations and inhalation devices - offer rapid and convenient delivery of medicines to the deep lung where they can exert an effect locally or enter the systemic circulation, depending on the target indication. We are committed to using our formulation capabilities and device engineering prowess to lessen the burden of diseases such as diabetes, nontuberculous mycobacterial (NTM) lung disease, pulmonary fibrosis, and pulmonary hypertension.